Medicine for treating dermatomyositis

Abstract

The invention relates to a medicine for treating dermatomyositis. The medicine is prepared from, by weight, 12 parts of Saxifraga stolonifera, 22 parts of plantain herb, 10 parts of radix achyranthis bidentatae, 12 parts of Adenophora stricta, 10 parts of cortex dictamni, 6 parts of herba schizonepetae, 4 parts of campsis grandiflora, 1 part of nux vomica and 22 parts of oldenlandia diffusa. The medicine has the advantages that the Saxifraga stolonifera can dispel wind, clear away heat and cool blood to remove pathogenic heat; the plantain herb can clear away heat, induce diuresis, and cool blood to remove pathogenic heat; the radix achyranthis bidentatae can nourish the liver and kidney, strength muscles and bones, activate blood to promote menstruation, lead fire to move downwards, and induce diuresis for treating stranguria; the Adenophora stricta can nourish yin to clear away heat, moisten the lung to remove phlegm, tonify the stomach and promote fluid; the cortex dictamni can clear away heat, expel dampness, dispel wind, arrest itching and detoxify; the herba schizonepetae can dispel wind to relieve exogenous syndrome, promote eruption and stop bleeding; the campsis grandiflora can clear away heat, cool blood, disperse blood stasis, remove stasis, dispel wind and arrest itching; the nux vomica can dredge collaterals, strengthen tendons, remove stasis , relieve pain, diminish swelling and achieve detoxification; the oldenlandia diffusa can clear away heat, detoxify and remove dampness. The medicines are mixed for use to achieve the effects of clearing away heat, eliminating dampness, conducting circulation of tendons and muscles, nourishing the liver and the kidney, reinforcing qi and nourishing blood. A clinical experiment proves that the medicine can safely and effectively treat dermatomyositis.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating dermatomyositis. Background technique [0002] Dermatomyositis is an autoimmune connective tissue disease characterized by skin and muscle damage, mainly involving striated muscle, and a non-suppurative inflammatory lesion dominated by lymphocyte infiltration, which may or may not be accompanied by various skin lesions . The onset may be related to factors such as tumors, infections, drugs, endocrine, and metabolism. Clinically, it is characterized by symmetrical limb girdle muscle, neck muscle and pharyngeal muscle weakness, affected skin (face, neck, eye area, etc.), lavender edematous erythema, myalgia, muscle weakness, etc., often involving multiple organs , It can also be accompanied by tumors and other connective tissue diseases, and those who only invade the muscles without skin damage are called polymyositis. Dermatomyositis can occur at any age...

AI Technical Summary

Problems solved by technology

However, the drug has a slow onset, usually after 3 months